SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-22-001132
Filing Date
2022-03-16
Accepted
2022-03-16 07:11:07
Documents
3
Period of Report
2022-03-16

Document Format Files

Seq Description Document Type Size
1 6-K zk2227490.htm 6-K 10662
2 FOURTH QUARTER 2021 FINANCIAL RESULTS exhibit_1.htm EX-99 396274
3 image0.jpg GRAPHIC 5551
  Complete submission text file 0001178913-22-001132.txt   415825
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 22743283
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences